Previous close | 3.2500 |
Open | 3.3500 |
Bid | 3.2300 x 400 |
Ask | 3.2800 x 100 |
Day's range | 3.2002 - 3.3500 |
52-week range | 1.5600 - 3.8800 |
Volume | |
Avg. volume | 1,476,378 |
Market cap | 47.293M |
Beta (5Y monthly) | 1.21 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
ARCA Biopharma Inc (NASDAQ:ABIO) and Oruka Therapeutics have entered into a definitive agreement to combine the companies in an all-stock transaction. Oruka Therapeutics is a privately held biotechnology company developing novel biologics for chronic skin diseases, including plaque psoriasis. The resulting entity will focus on advancing Oruka’s pipeline, including ORKA-001 (an IL-23p19 inhibitor) and ORKA-002 (an IL-17A/F inhibitor). Upon completion of the merger, the combined company plans to o
Just because a business does not make any money, does not mean that the stock will go down. For example, although...